3rd Quarter - Report

CGCN GROUP, LLC for EMERGENT BIOSOLUTIONS INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.

LobbyistCovered position, as disclosed
JILL HAMAKER —
MARTHA BEATRICE MILLER —
SCOTT RIPLINGER —
JA'RON SMITH New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2483 (119th), H.R. 5252 (119th), H.R. 1968 (119th)

Homeland Security HOM

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.

LobbyistCovered position, as disclosed
JILL HAMAKER —
MARTHA BEATRICE MILLER —
SCOTT RIPLINGER —
JA'RON SMITH New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5252 (119th), H.R. 2483 (119th), H.R. 1968 (119th)

Budget/Appropriations BUD

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.

LobbyistCovered position, as disclosed
JILL HAMAKER —
MARTHA BEATRICE MILLER —
SCOTT RIPLINGER —
JA'RON SMITH New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5252 (119th), H.R. 2483 (119th), H.R. 1968 (119th)

Disaster Planning/Emergencies DIS

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.

LobbyistCovered position, as disclosed
JILL HAMAKER —
MARTHA BEATRICE MILLER —
SCOTT RIPLINGER —
JA'RON SMITH New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5252 (119th), H.R. 2483 (119th), H.R. 1968 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.